Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

PURPOSE: To evaluate the impact of two different intraperitoneal (IP) chemotherapy regimens on progression-free survival (PFS) among women with newly diagnosed advanced ovarian carcinoma. METHODS: Eligible patients were randomly assigned to six cycles of IV paclitaxel 80 mg/m(2) once per week with i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Oncol
Hauptverfasser: Walker, Joan L., Brady, Mark F., Wenzel, Lari, Fleming, Gini F., Huang, Helen Q., DiSilvestro, Paul A., Fujiwara, Keiichi, Alberts, David S., Zheng, Wenxin, Tewari, Krishnansu S., Cohn, David E., Powell, Matthew A., Van Le, Linda, Davidson, Susan A., Gray, Heidi J., Rose, Peter G., Aghajanian, Carol, Myers, Tashanna, Alvarez Secord, Angeles, Rubin, Stephen C., Mannel, Robert S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Clinical Oncology 2019
Schlagworte:
ORIGINAL REPORTS
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544459/
https://ncbi.nlm.nih.gov/pubmed/31002578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.01568
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge